Microbix Develops Team to Help Boost Flu Vaccine Production

August 16, 2007
Pharmaceutical Technology Editors
ePT--the Electronic Newsletter of Pharmaceutical Technology

Microbix Biosystems has established a team of experts to help manufacturers boost their production of influenza vaccine.

Toronto, ON, Canada (Aug. 13)-Microbix Biosystems has established a team of experts to help manufacturers boost their production of influenza vaccine. The “Special Workgroup for Applied Technology Transfer” or “SWATT” group, working with the company’s “VirusMax” technology, spends several weeks at each facility to help implement the technology and train personnel.

The VirusMax technology is designed to increase the virus yield from eggs by effectively recovering the virus. “Our technology can be installed very quickly, and with limited capital costs into existing manufacturing processes,” said William J. Gastle, CEO of Microbix, in a prepared statement. According to the company, the technology has been shown to double vaccine production.